Haleon Pakistan Limited (HALEON) Share Price – Pakistan Stock Exchange (PSX)
Haleon Pakistan Limited
HALEONPHARMACEUTICALS·3rd of 14 by market cap
Prev Close774.47
Open774.48
Day Change+9.25+1.19%
Volume56.6K
YTD Return-14.50%
Day Range
768.01
794.90
52W Range
655.00
1,010.00
Key Metrics
RevRevenueGood
Rs. 43.11 B
ProfitNet ProfitGood
Rs. 6.37 B
EPSEPSGood
₨54.45
ROEROEAvg
43.1%
P/EP/EAvg
14.4x
YieldDiv YieldLow
3.8%
Haleon Pakistan Limited has shown positive revenue growth of 15.9% over the past year. Net income has grown by 39.2% year-over-year. The company maintains a return on equity of 10.5%.
Company Profile
About Haleon Pakistan Limited
HALEON · PHARMACEUTICALS
Haleon Pakistan Limited (formerly known as GlaxoSmithKline Consumer Healthcare Pakistan Limited) was incorporated in Pakistan as a public listed company under the provisions of the repealed Companies Ordinance, 1984 (now Companies Act, 2017) on 31 March 2015. The Company is a subsidiary of ‘Haleon Netherlands B.V’. The ultimate parent of the Company is Haleon plc. The Company is inter alia principally engaged in the manufacturing, marketing and sale of consumer healthcare and over the counter health products.